Cure The Future are proud to announce that Prof John Rasko and his team at the Centenary Institute at Royal Prince Alfred Hospital in Sydney are to receive a major grant from the Cancer Council to help fund the new CAR-T therapy trials, which are also a focus of our current fundraising at Cure The Future.
This comes as part of over $10 million of funding into a number of ground-breaking cancer research projects announced by Cancer Council NSW, which includes a seperate grant to Assoc. Prof. Jeff Holst, who is also a member of Prof. Rasko’s team.
Winning grants revealed at 2018 Research Awards
Cancer Council NSW has awarded over $10.6 million to 17 outstanding cancer research projects. The grants help fund future breakthroughs in cancer research – the awarded research teams are leading the charge towards a cancer free future by investigating new ways to treat the disease.
The 2018 grants were announced and awarded at Cancer Council NSW’s annual Research Awards, this year held in the evening of 27 March at Westpac’s Barangaroo Towers in Sydney.
“We are excited to announce a round of extraordinary projects – all 17 recipients are extraordinary scientists who do essential and highly innovative work,” said Dr Jane Hobson, Research Grants Manager at Cancer Council NSW.
The majority of the 17 projects announced last night – awarded to the Centenary Institute, Children’s Cancer Institute, Garvan Institute of Medical Research, UNSW Sydney, University of Sydney and UTS – are three-year Project Grants. One Infrastructure Grant is going to Children’s Medical Research Institute.
Two projects received a Pathways to a cancer free future grant. The recipients of those grants are Professor John Rasko at Royal Prince Alfred Hospital (grant for $2m) and Professor Jennifer Martin at the University of Newcastle (grant for $1.96m).
Professor Rasko and team will be trialling a potential new treatment for pancreatic cancer known as CAR T-cell immunotherapy. The treatment involves taking a patient’s white blood cells, growing them in the laboratory, genetically modifying specific cells to attack only cancer cells, and then returning them to the patient. The grant provides much-needed hope for patients who receive the devastating diagnosis of pancreatic cancer (which has one of the lowest survival rates).
Professor Martin and her team will test and validate how new technologies could be used to monitor the concentration of chemotherapy in a patient’s blood in fast-tracked timeframes to provide optimal treatment dosing. It is hoped that this research will lead to direct and significant benefits in patient dosing, across wide population groups and in rural and remote areas, to improve quality of life, reduce side effects and increase chance of survival.
“The broad range of projects that we fund – across many types of cancers and stages of the cancer journey – shows Cancer Council NSW’s commitment to work across every area of every cancer,” Dr Hobson said.
“Projects like Professor Rasko’s and Professor Martin’s wouldn’t be possible without our supporters – as an organisation that is over 95% community funded, these grants have been made possible by the community,” Dr Hobson concluded.
– did you know?
- Pancreatic Cancer has the highest mortality rate of all cancers
- The survival rate has not improved in 40 years
- Since 1996, 1 million families have lost someone to Pancreatic Cancer
- 91% of patients die
- By 2020 Pancreatic Cancer will be the 2nd leading cause of cancer-related deaths
- It receives only 2% of federal cancer funding in the US
The event is also an important opportunity to celebrate the research achievements of Cancer Council NSW over the last year, and to thank staff and donors for their ongoing support of cancer research.
Cancer Council NSW 2018 Pathways to a Cancer Free Future Grant recipients:
- Professor John Rasko, Royal Price Alfred Hospital: Can a revolutionary new immunotherapy fight pancreatic cancer?
- Professor Jennifer Martin, The University of Newcastle: Improving patient outcomes through personalised chemotherapy dosing
Cancer Council NSW 2018 Infrastructure Grant recipient:
- Professor Roger Reddel, Children’s Medical Research Institute: Building research infrastructure to enable clinicians to choose the right treatment for the right patient
Cancer Council NSW 2018 Project Grant recipients:
- Professor Peter Hersey, Centenary Institute: Exploring the role of T cells when immunotherapy for melanoma fails.
- A/Professor Jeffery Holst, Centenary Institute: A targeted approach to triple-negative breast cancer
- Dr Umaimainthan Palendira, Centenary Institute: Improving immunotherapy for melanoma
- Dr Jessamy Tiffen, Centenary Institute: Improving drug treatment for melanoma
- A/Professor Tao Liu, Children’s Cancer Institute: Investigating a new therapy for a problematic childhood cancer
- Dr David Gallego Ortega, Garvan Institute of Medical Research: A ‘molecular microscope’ approach to develop immune therapy for breast cancer
- Dr Ruth Pidsley, Garvan Institute of Medical Research: Improving prostate cancer treatment to minimise side effects
- Professor Susan Ramus, UNSW Sydney: Moving towards personalised treatments for ovarian cancer
- Professor Barbara Fazekas de St Groth, University of Sydney: Predicting responses to cancer immunotherapy
- Professor Jacob George, University of Sydney: A new approach to fighting drug resistance in liver cancer
- Professor David Gottlieb, University of Sydney: The Susan and John Freeman Research Grant: A new approach to boosting resistance to fungal infection in cancer patients
- Professor Elizabeth Sullivan, UTS: Cancer and Outcomes in Pregnancy – A NSW Evaluation (COPE)
Recipients of a Cancer Australia PdCCRS project grant, co-funded by Cancer Council NSW:
- Dr Marina Pajic, Garvan Institute of Medical Research: Improving pancreatic cancer treatment through a ‘personalised medicine’ approach
- A/Professor Ilona Juraskova, University of Sydney: Enhancing carer involvement in a patient’s cancer care